Brookfield Asset Management Inc. Edwards Lifesciences Corp Transaction History

Brookfield Asset Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Sep 25, 2023	BUY	$74.26 - $84.51 $207,705 - $236,374	2,797 New	2,797 $231,000
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $207,705 - $236,374	2,797 New	2,797 $231,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $2.71 Million - $3.53 Million	32,940 New	32,940 $2.72 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $1.09 Million - $1.38 Million	-10,729 Reduced 37.03%	18,241 $2.15 Million
Q2 2021 Aug 17, 2021	SELL	$83.84 - $104.76 $1.32 Million - $1.65 Million	-15,768 Reduced 35.25%	28,970 $3 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $2.57 Million - $3.44 Million	44,738 New	44,738 $3.09 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.